Stock MLYS MINERALYS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Mineralys Therapeutics, Inc.

Equities

MLYS

US6031701013

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
13.52 USD -5.26% Intraday chart for Mineralys Therapeutics, Inc. +4.40% +57.21%
May. 09 Transcript : Mineralys Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024
May. 09 Mineralys Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Mineralys Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024
Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
AQ
Mineralys Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference
AQ
Mineralys Therapeutics to Announce First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 9, 2024
AQ
Mineralys Therapeutics, Inc. Announces Alexander Asam Informs That His Decision Not to Stand for Re-Election to the Board
CI
Goldman Sachs Initiates Mineralys Therapeutics at Buy With $30 Price Target
MT
Mineralys Therapeutics Files Mixed-Securities Shelf Registration
MT
Transcript : Mineralys Therapeutics, Inc., Q4 2023 Earnings Call, Mar 21, 2024
Mineralys Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Mineralys Therapeutics : Corporate Overview March 2024
PU
Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
AQ
Mineralys Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
North American Morning Briefing : Investors -2-
DJ
Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on Thursday, March 21, 2024
AQ
Sector Update: Health Care Stocks Ease in Late Afternoon
MT
Sector Update: Health Care
MT
Mineralys Therapeutics Secures $120 Million Financing Through Private Placement; Shares Rise
MT
Mineralys Therapeutics Announces $120 Million Private Placement Financing
AQ
Mineralys Therapeutics, Inc. announced that it expects to receive $119.999925 million in funding from TCG Crossover Management, LLC, OrbiMed Advisors LLC, RA Capital Management, L.P., Samsara BioCapital LLC, VR Adviser, LLC
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MLYS Stock
  4. News Mineralys Therapeutics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW